ID   EST1D_RAT               Reviewed;         565 AA.
AC   P16303; Q64574; Q6P785; Q91YG2; Q9QUX7; Q9R135;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2004, sequence version 2.
DT   24-JUL-2024, entry version 168.
DE   RecName: Full=Carboxylesterase 1D {ECO:0000305};
DE   AltName: Full=Carboxyesterase ES-10 {ECO:0000303|PubMed:12230550};
DE   AltName: Full=Carboxylesterase 3;
DE            EC=3.1.1.1;
DE            EC=3.1.1.67;
DE   AltName: Full=ES-HVEL;
DE   AltName: Full=Fatty acid ethyl ester synthase;
DE            Short=FAEE synthase;
DE   AltName: Full=Liver carboxylesterase 10;
DE   AltName: Full=pI 6.1 esterase;
DE   Flags: Precursor;
GN   Name=Ces1d {ECO:0000312|RGD:70896}; Synonyms=Ces3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley, and Wistar; TISSUE=Liver;
RX   PubMed=2386485; DOI=10.1042/bj2690451;
RA   Robbi M., Beaufay H., Octave J.-N.;
RT   "Nucleotide sequence of cDNA coding for rat liver pI 6.1 esterase (ES-10),
RT   a carboxylesterase located in the lumen of the endoplasmic reticulum.";
RL   Biochem. J. 269:451-458(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=1606962; DOI=10.1111/j.1432-1033.1992.tb16987.x;
RA   Medda S., Proia R.L.;
RT   "The carboxylesterase family exhibits C-terminal sequence diversity
RT   reflecting the presence or absence of endoplasmic-reticulum-retention
RT   sequences.";
RL   Eur. J. Biochem. 206:801-806(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=8541339; DOI=10.1016/0005-2760(95)00184-0;
RA   Ghosh S., Mallonee D.H., Hylemon P.B., Grogan W.M.;
RT   "Molecular cloning and expression of rat hepatic neutral cholesteryl ester
RT   hydrolase.";
RL   Biochim. Biophys. Acta 1259:305-312(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND MUTAGENESIS OF GLN-186; MET-423; SER-491;
RP   LYS-492 AND ASN-506.
RC   STRAIN=Sprague-Dawley; TISSUE=Lung;
RX   PubMed=11429416; DOI=10.1074/jbc.m105644200;
RA   Wallace T.J., Kodsi E.M., Langston T.B., Gergis M.R., Grogan W.M.;
RT   "Mutation of residues 423 (Met/Ile), 444 (Thr/Met), and 506 (Asn/Ser)
RT   confer cholesteryl esterase activity on rat lung carboxylesterase. Ser-506
RT   is required for activation by cAMP-dependent protein kinase.";
RL   J. Biol. Chem. 276:33165-33174(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Ryu J.W., Lee W., Jung C.Y.;
RT   "Rattus norvegicus adipocyte carboxylesterase mRNA.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 19-45, FUNCTION, CATALYTIC ACTIVITY, ACTIVITY
RP   REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Adipose tissue;
RX   PubMed=1429692; DOI=10.1016/s0021-9258(18)35865-4;
RA   Tsujita T., Okuda H.;
RT   "Fatty acid ethyl ester synthase in rat adipose tissue and its relationship
RT   to carboxylesterase.";
RL   J. Biol. Chem. 267:23489-23494(1992).
RN   [8]
RP   PROTEIN SEQUENCE OF 19-38, NUCLEOTIDE SEQUENCE [MRNA] OF 113-121; 138-149;
RP   216-224; 350-356 AND 464-469, AND SUBUNIT.
RC   TISSUE=Liver;
RX   PubMed=8597091; DOI=10.1016/0378-4274(95)03493-5;
RA   Satoh T., Hosokawa M.;
RT   "Molecular aspects of carboxylesterase isoforms in comparison with other
RT   esterases.";
RL   Toxicol. Lett. 82:439-445(1995).
RN   [9]
RP   CATALYTIC ACTIVITY, FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=12230550; DOI=10.1046/j.1432-1033.2002.03121.x;
RA   Sanghani S.P., Davis W.I., Dumaual N.G., Mahrenholz A., Bosron W.F.;
RT   "Identification of microsomal rat liver carboxylesterases and their
RT   activity with retinyl palmitate.";
RL   Eur. J. Biochem. 269:4387-4398(2002).
CC   -!- FUNCTION: Major lipase in white adipose tissue (By similarity).
CC       Involved in the metabolism of xenobiotics and of natural substrates.
CC       Hydrolyzes triacylglycerols and monoacylglycerols, with a preference
CC       for monoacylglycerols. The susceptibility of the substrate increases
CC       with decreasing acyl chain length of the fatty acid moiety. Catalyzes
CC       the synthesis of fatty acid ethyl esters (PubMed:1429692). Hydrolyzes
CC       retinyl esters (PubMed:12230550). {ECO:0000250|UniProtKB:Q8VCT4,
CC       ECO:0000269|PubMed:12230550, ECO:0000269|PubMed:1429692}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=all-trans-retinyl hexadecanoate + H2O = all-trans-retinol +
CC         H(+) + hexadecanoate; Xref=Rhea:RHEA:13933, ChEBI:CHEBI:7896,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17336,
CC         ChEBI:CHEBI:17616; Evidence={ECO:0000269|PubMed:12230550};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13934;
CC         Evidence={ECO:0000305|PubMed:12230550};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a carboxylic ester + H2O = a carboxylate + an alcohol + H(+);
CC         Xref=Rhea:RHEA:21164, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29067, ChEBI:CHEBI:30879, ChEBI:CHEBI:33308; EC=3.1.1.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10039,
CC         ECO:0000269|PubMed:1429692};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a long-chain fatty acyl ethyl ester + H2O = a long-chain fatty
CC         acid + ethanol + H(+); Xref=Rhea:RHEA:16641, ChEBI:CHEBI:13209,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:16236,
CC         ChEBI:CHEBI:57560; EC=3.1.1.67;
CC         Evidence={ECO:0000269|PubMed:1429692};
CC   -!- ACTIVITY REGULATION: FAEE-synthesizing and PNPB-hydrolyzing activities
CC       are both inhibited by DFP. {ECO:0000269|PubMed:1429692}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.71 M for oleic acid {ECO:0000269|PubMed:1429692};
CC         KM=1.16 uM for retinyl palmitate {ECO:0000269|PubMed:12230550};
CC         Vmax=1482 nmol/h/mg enzyme toward oleic acid
CC         {ECO:0000269|PubMed:1429692};
CC         Note=kcat is 0.22 min(-1) with retinyl palmitate as substrate.
CC         {ECO:0000269|PubMed:12230550};
CC       pH dependence:
CC         Optimum pH for FAEE synthesis is 7.0. Optimum pH for PNPB-hydrolyzing
CC         activity is 6-8. {ECO:0000269|PubMed:1429692};
CC   -!- SUBUNIT: Homotrimer. {ECO:0000269|PubMed:8597091}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000250|UniProtKB:Q8VCT4}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q8VCT4}. Lipid droplet
CC       {ECO:0000250|UniProtKB:Q8VCT4}. Microsome
CC       {ECO:0000269|PubMed:12230550}.
CC   -!- TISSUE SPECIFICITY: Detected in liver, lung and testis, but not in
CC       kidney (at protein level). {ECO:0000269|PubMed:12230550,
CC       ECO:0000269|PubMed:1429692}.
CC   -!- SIMILARITY: Belongs to the type-B carboxylesterase/lipase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X51974; CAA36236.1; -; mRNA.
DR   EMBL; X65296; CAA46391.1; -; mRNA.
DR   EMBL; L46791; AAA88507.1; -; mRNA.
DR   EMBL; L81144; AAL00849.1; -; mRNA.
DR   EMBL; AF171640; AAD49369.1; -; mRNA.
DR   EMBL; BC061789; AAH61789.1; -; mRNA.
DR   PIR; A45140; A45140.
DR   PIR; S10367; S10367.
DR   RefSeq; NP_579829.3; NM_133295.3.
DR   AlphaFoldDB; P16303; -.
DR   SMR; P16303; -.
DR   STRING; 10116.ENSRNOP00000021812; -.
DR   SwissLipids; SLP:000001457; -.
DR   ESTHER; ratno-Ces1d; Carb_B_Chordata.
DR   CarbonylDB; P16303; -.
DR   GlyCosmos; P16303; 2 sites, No reported glycans.
DR   GlyGen; P16303; 2 sites.
DR   iPTMnet; P16303; -.
DR   PhosphoSitePlus; P16303; -.
DR   PaxDb; 10116-ENSRNOP00000021812; -.
DR   GeneID; 113902; -.
DR   KEGG; rno:113902; -.
DR   AGR; RGD:1359640; -.
DR   AGR; RGD:70896; -.
DR   CTD; 104158; -.
DR   RGD; 70896; Ces1d.
DR   eggNOG; KOG1516; Eukaryota.
DR   InParanoid; P16303; -.
DR   OrthoDB; 4386at2759; -.
DR   PhylomeDB; P16303; -.
DR   BRENDA; 3.1.1.1; 5301.
DR   Reactome; R-RNO-2022377; Metabolism of Angiotensinogen to Angiotensins.
DR   Reactome; R-RNO-211945; Phase I - Functionalization of compounds.
DR   Reactome; R-RNO-5578768; Physiological factors.
DR   Reactome; R-RNO-9749641; Aspirin ADME.
DR   SABIO-RK; P16303; -.
DR   PRO; PR:P16303; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; ISS:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:UniProtKB.
DR   GO; GO:0005811; C:lipid droplet; ISS:UniProtKB.
DR   GO; GO:0047376; F:all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity; IEA:RHEA.
DR   GO; GO:0106435; F:carboxylesterase activity; ISO:RGD.
DR   GO; GO:0052689; F:carboxylic ester hydrolase activity; ISO:RGD.
DR   GO; GO:0030339; F:fatty-acyl-ethyl-ester synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050253; F:retinyl-palmitate esterase activity; IDA:UniProtKB.
DR   GO; GO:0004771; F:sterol esterase activity; ISS:UniProtKB.
DR   GO; GO:0004806; F:triglyceride lipase activity; ISS:UniProtKB.
DR   GO; GO:0046464; P:acylglycerol catabolic process; ISS:UniProtKB.
DR   GO; GO:0071397; P:cellular response to cholesterol; ISO:RGD.
DR   GO; GO:0070417; P:cellular response to cold; ISO:RGD.
DR   GO; GO:0071404; P:cellular response to low-density lipoprotein particle stimulus; ISO:RGD.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; ISO:RGD.
DR   GO; GO:0042632; P:cholesterol homeostasis; ISO:RGD.
DR   GO; GO:0008203; P:cholesterol metabolic process; ISO:RGD.
DR   GO; GO:0060086; P:circadian temperature homeostasis; ISO:RGD.
DR   GO; GO:0106106; P:cold-induced thermogenesis; ISO:RGD.
DR   GO; GO:0061725; P:cytosolic lipolysis; ISO:RGD.
DR   GO; GO:0030855; P:epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0016042; P:lipid catabolic process; ISO:RGD.
DR   GO; GO:0051791; P:medium-chain fatty acid metabolic process; ISO:RGD.
DR   GO; GO:0010887; P:negative regulation of cholesterol storage; ISO:RGD.
DR   GO; GO:0010875; P:positive regulation of cholesterol efflux; ISO:RGD.
DR   GO; GO:0090205; P:positive regulation of cholesterol metabolic process; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0070857; P:regulation of bile acid biosynthetic process; ISO:RGD.
DR   GO; GO:0120188; P:regulation of bile acid secretion; ISO:RGD.
DR   GO; GO:0001523; P:retinoid metabolic process; TAS:UniProtKB.
DR   GO; GO:0043691; P:reverse cholesterol transport; ISO:RGD.
DR   GO; GO:0019626; P:short-chain fatty acid catabolic process; ISO:RGD.
DR   GO; GO:0034379; P:very-low-density lipoprotein particle assembly; ISO:RGD.
DR   CDD; cd00312; Esterase_lipase; 1.
DR   Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR002018; CarbesteraseB.
DR   InterPro; IPR019826; Carboxylesterase_B_AS.
DR   InterPro; IPR019819; Carboxylesterase_B_CS.
DR   InterPro; IPR050309; Type-B_Carboxylest/Lipase.
DR   PANTHER; PTHR11559; CARBOXYLESTERASE; 1.
DR   PANTHER; PTHR11559:SF179; LIVER CARBOXYLESTERASE 1-RELATED; 1.
DR   Pfam; PF00135; COesterase; 1.
DR   SUPFAM; SSF53474; alpha/beta-Hydrolases; 1.
DR   PROSITE; PS00122; CARBOXYLESTERASE_B_1; 1.
DR   PROSITE; PS00941; CARBOXYLESTERASE_B_2; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Direct protein sequencing; Disulfide bond;
KW   Endoplasmic reticulum; Glycoprotein; Hydrolase; Lipid degradation;
KW   Lipid droplet; Lipid metabolism; Microsome; Reference proteome;
KW   Serine esterase; Signal.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000269|PubMed:1429692,
FT                   ECO:0000269|PubMed:8597091"
FT   CHAIN           19..565
FT                   /note="Carboxylesterase 1D"
FT                   /id="PRO_0000008584"
FT   MOTIF           562..565
FT                   /note="Prevents secretion from ER"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        221
FT                   /note="Acyl-ester intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10039"
FT   ACT_SITE        353
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:P23141"
FT   ACT_SITE        466
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:P23141"
FT   MOD_RES         382
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VCT4"
FT   CARBOHYD        79
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        489
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        87..116
FT                   /evidence="ECO:0000250|UniProtKB:P23141"
FT   DISULFID        273..284
FT                   /evidence="ECO:0000250|UniProtKB:P23141"
FT   MUTAGEN         186
FT                   /note="Q->R: No effect on the hydrolysis of PNPC or PNPA,
FT                   no activity on cholesteryl oleate. No effect on the
FT                   hydrolysis of PNPC or PNPA, no activity on cholesteryl
FT                   oleate; when associated with E-492; or with T-491 and E-
FT                   492. Increases activity on PNPC compared to activity on
FT                   PNPA; when associated with I-423; T-491 and E-492."
FT                   /evidence="ECO:0000269|PubMed:11429416"
FT   MUTAGEN         423
FT                   /note="M->I: Increases specific activity against PNPC by 8-
FT                   fold, does not increase activity against PNPA, no activity
FT                   on cholesteryl oleate. Increases activity on PNPC compared
FT                   to activity on PNPA; when associated with R-186; T-491 and
FT                   E-492. Increases specific activity against PNPC by 7.5-fold
FT                   and against PNPA by 3.6-fold, and increases cholesteryl
FT                   esterase activity by 2.7 fold; when associated with S-506."
FT                   /evidence="ECO:0000269|PubMed:11429416"
FT   MUTAGEN         491
FT                   /note="S->T: No effect on the hydrolysis of PNPC or PNPA,
FT                   no activity on cholesteryl oleate; when associated with R-
FT                   186 and E-492. Increases activity on PNPC compared to
FT                   activity on PNPA; when associated with R-186; I-423 and E-
FT                   492."
FT                   /evidence="ECO:0000269|PubMed:11429416"
FT   MUTAGEN         492
FT                   /note="K->E: No effect on the hydrolysis of PNPC or PNPA,
FT                   no activity on cholesteryl oleate; when associated with R-
FT                   186; or with R-186 and T-491. Increases activity on PNPC
FT                   compared to activity on PNPA; when associated with R-186;
FT                   I-423 and T-491."
FT                   /evidence="ECO:0000269|PubMed:11429416"
FT   MUTAGEN         506
FT                   /note="N->S: Increases specific activity against PNPC by 6-
FT                   fold and against PNPA by 8.7-fold, no activity on
FT                   cholesteryl oleate. Increases specific activity against
FT                   PNPC by 7.5-fold and against PNPA by 3.6-fold, and
FT                   increases cholesteryl esterase activity by 2.7 fold; when
FT                   associated with I-423."
FT                   /evidence="ECO:0000269|PubMed:11429416"
FT   CONFLICT        186
FT                   /note="Q -> R (in Ref. 1; CAA36236, 3; AAA88507 and 5;
FT                   AAD49369)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        265
FT                   /note="N -> K (in Ref. 1; CAA36236)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        420
FT                   /note="A -> E (in Ref. 3; AAA88507)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        423
FT                   /note="M -> I (in Ref. 1; CAA36236, 3; AAA88507 and 5;
FT                   AAD49369)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        444
FT                   /note="M -> T (in Ref. 4; AAL00849)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        491..492
FT                   /note="SK -> TQ (in Ref. 3; AAA88507)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        506
FT                   /note="N -> S (in Ref. 1; CAA36236, 3; AAA88507 and 5;
FT                   AAD49369)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   565 AA;  62147 MW;  F3277B7FAD2141A4 CRC64;
     MRLYPLVWLF LAACTAWGYP SSPPVVNTVK GKVLGKYVNL EGFAQPVAVF LGIPFAKPPL
     GSLRFAPPQP AEPWNFVKNT TSYPPMCSQD AVGGQVLSEL FTNRKENIPL QFSEDCLYLN
     VYTPADLTKN SRLPVMVWIH GGGLVVGGAS TYDGQVLSAH ENVVVVTIQY RLGIWGFFST
     GDEHSQGNWG HLDQVAALHW VQDNIANFGG NPGSVTIFGE SAGGFSVSAL VLSPLAKNLF
     HRAISESGVV LTSALITTDS KPIANLIATL SGCKTTTSAV MVHCLRQKTE DELLETSLKL
     NLFKLDLLGN PKESYPFLPT VIDGVVLPKT PEEILAEKSF NTVPYIVGIN KQEFGWIIPT
     LMGYPLSEGK LDQKTAKSLL WKSYPTLKIS EKMIPVVAEK YFGGTDDPAK RKDLFQDLVA
     DVMFGVPSVM VSRSHRDAGA PTFMYEFEYR PSFVSAMRPK TVIGDHGDEL FSVFGSPFLK
     DGASEEETNL SKMVMKYWAN FARNGNPNGG GLPHWPEYDQ KEGYLKIGAS TQAAQRLKDK
     EVAFWSELRA KEAAEEPSHW KHVEL
//
